Healthcare & Life Sciences
NorthSea Therapeutics
Netherlandswww.northseatherapeutics.com
aliveseries-c-plus
series-c-plus
Stage
2
Investors
About
NorthSea Therapeutics is a clinical-stage biotechnology company developing structurally engineered fatty acids (SEFAs) for the treatment of metabolic, inflammatory, and fibrotic diseases, including NASH, MASH, and intestinal failure-associated liver disease (IFALD).
Explore NorthSea Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.